Conference Correspondent

Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent — June 1, 2014

Early Predictors of Overall Survival in mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — June 1, 2014

The Current Status of Biomarkers in Use for the Treatment of Patients with mCRC

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — June 1, 2014

Updated Results of the SOFT Study

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent — June 1, 2014

A Mutant-Selective EGFR Inhibitor in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — June 1, 2014

Ceritinib in Advanced ALK-Rearranged NSCLC: Results from the ASCEND-1 Trial

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — June 1, 2014

Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — June 1, 2014

Results from RADIANT: Adjuvant Erlotinib in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — June 1, 2014

Breaking News from the REVEL Study in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — June 1, 2014

NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent — May 31, 2014

Page 41 of 44

38
39
40
41
42
43
44